John M. Zajecka, MD
- 22Articles
- 84.7KReads
- 2000–2016Active
- 70Collaborators
- 274Citations
About
John M. Zajecka, MD, has published extensively on the treatment and management of major depressive disorder (MDD), bipolar disorder, and mood disorders, with a focus on adjunctive therapies such as l-methylfolate and pharmacologic strategies including selective serotonin reuptake inhibitors and ziprasidone. His work also addresses residual symptoms, relapse prevention, and the impact of factors like obesity and inflammatory markers on treatment outcomes. Additionally, he has contributed to research on neurology, child and adolescent psychiatry, seizures, and weight-related issues in psychiatric populations.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
